ABCL AbCellera Biologics Inc.
$13.91
AbCellera Biologics Inc. (ABCL) Earnings News
Earnings press releases, previews and reviews for AbCellera Biologics Inc. (ABCL), newest first.
Thursday
October 1, 2026
4:05 PM ET
AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026
Wednesday
August 5, 2026
4:05 PM ET
AbCellera Reports Q2 2026 Business Results
Thursday
July 23, 2026
9:05 AM ET
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
Wednesday
July 15, 2026
8:45 AM ET
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
Tuesday
July 7, 2026
4:05 PM ET
AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026
Monday
May 11, 2026
4:05 PM ET
AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635
Monday
April 20, 2026
9:00 AM ET
AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call